Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | HTR7 | P34969 | 2/20 | 0.41 |
| ▸ | HTR2B | P41595 | 2/20 | 0.41 |
| ▸ | DRD2 | P14416 | 3/20 | 0.40 |
| ▸ | DRD4 | P21917 | 2/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.40 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.35 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.35 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535107 | 0.90 | PNMT (0.54) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL647004 | 0.87 | PNMT (0.51) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL7036967 | 0.87 | PNMT (0.55) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL1830400 | 0.85 | PNMT (0.55) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL7406401 | 0.81 | PNMT (0.45) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL1830397 | 0.81 | PNMT (0.57) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL7699410 | 0.81 | PNMT (0.50) | PNMTNPC1RAB9AHTR7HTR2B | |
| Benzene SCHEMBL28021305 | 0.80 | PNMT (0.53) | PNMTNPC1RAB9AHTR7HTR2B | |
| Glycine SCHEMBL15362023 | 0.80 | PNMT (0.56) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL8671794 | 0.79 | PNMT (0.55) | PNMTNPC1RAB9AHTR7HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012131077-A1 | SOMATOSTATIN MIMETICS | NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) | 2012-10-04 | — | — | WO | claimed |
| US-11333976-B2 | Resin, photosensitive resin composition, electronic component and display device using the same | TORAY INDUSTRIES, INC. (JP) | 2022-05-17 | — | — | US | disclosed |
| WO-2012131077-A1 | SOMATOSTATIN MIMETICS | NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) | 2012-10-04 | — | — | WO | disclosed |
| EP-1027070-A4 | CONJUGATE HEAT SHOCK PROTEIN-BINDING PEPTIDES | SLOAN KETTERING INSTITUTEFOR C (US) | 2004-08-18 | — | — | EP | disclosed |
| US-20030194409-A1 | Conjugate heat shock protein-binding peptides | ROTHMAN JAMES E (US) | 2003-10-16 | — | — | US | disclosed |
| US-20030166530-A1 | Conjugate heat shock protein-binding peptides | ROTHMAN JAMES E (US) | 2003-09-04 | — | — | US | disclosed |
| US-20030134787-A1 | Conjugate heat shock protein-binding peptides | ROTHMAN JAMES E (US) | 2003-07-17 | — | — | US | disclosed |
| EP-1027070-A1 | CONJUGATE HEAT SHOCK PROTEIN-BINDING PEPTIDES | Sloan-Kettering Institute For Cancer Research (US) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999022761-A9 | CONJUGATE HEAT SHOCK PROTEIN-BINDING PEPTIDES | SLOAN KETTERING INST CANCER (US) | 1999-08-12 | — | — | WO | disclosed |
| WO-1999022761-A1 | CONJUGATE HEAT SHOCK PROTEIN-BINDING PEPTIDES | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1999-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11333976-B2 | Resin, photosensitive resin composition, electronic component and display device using the same | EED, RPL19, RARA | PNMT 2745/4885NPC1 4393/4885RAB9A 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.